| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $510.9M | +4.0% |
| Cost of Revenue | $323.4M | -0.1% |
| Gross Profit | $187.5M | +11.9% |
| R&D Expense | $73.2M | +6.6% |
| SG&A Expense | $72.1M | +28.0% |
| Operating Income | -$34.9M | -40.1% |
| Pre-tax Income | -$29.4M | -41.0% |
| Income Tax | $1.1M | -7.1% |
| Net Income | -$30.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $82.0M | +45.1% |
| Accounts Receivable | $57.3M | -12.3% |
| Inventory | $40.6M | +5.8% |
| Current Assets | $262.6M | +4.8% |
| Total Assets | $298.4M | +4.5% |
| Current Liabilities | $176.8M | +9.5% |
| Total Liabilities | $197.5M | +8.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.3M | +34.0% |
| Capital Expenditures | $2.7M | -5.6% |
| Investing Cash Flow | $10.8M | +121.4% |
| Financing Cash Flow | -$40.8M | -169.2% |
| Free Cash Flow | $48.6M | +37.1% |
| -38.4% |
| EPS (Basic) | -$0.31 | -29.2% |
| EPS (Diluted) | -$0.31 | -29.2% |
| Stockholders' Equity |
| $100.9M |
| -2.3% |